330 related articles for article (PubMed ID: 26443432)
41. Collision tumors revealed by prospectively assessing subtype-defining molecular alterations in 904 individual prostate cancer foci.
Fontugne J; Cai PY; Alnajar H; Bhinder B; Park K; Ye H; Beg S; Sailer V; Siddiqui J; Blattner-Johnson M; Croyle JA; Noorzad Z; Calagua C; MacDonald TY; Axcrona U; Bogaard M; Axcrona K; Scherr DS; Sanda MG; Johannessen B; Chinnaiyan AM; Elemento O; Skotheim RI; Rubin MA; Barbieri CE; Mosquera JM
JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35050902
[TBL] [Abstract][Full Text] [Related]
42. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
[TBL] [Abstract][Full Text] [Related]
43. ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss.
Chen Y; Chi P; Rockowitz S; Iaquinta PJ; Shamu T; Shukla S; Gao D; Sirota I; Carver BS; Wongvipat J; Scher HI; Zheng D; Sawyers CL
Nat Med; 2013 Aug; 19(8):1023-9. PubMed ID: 23817021
[TBL] [Abstract][Full Text] [Related]
44. SPINK1 protein expression and prostate cancer progression.
Flavin R; Pettersson A; Hendrickson WK; Fiorentino M; Finn S; Kunz L; Judson GL; Lis R; Bailey D; Fiore C; Nuttall E; Martin NE; Stack E; Penney KL; Rider JR; Sinnott J; Sweeney C; Sesso HD; Fall K; Giovannucci E; Kantoff P; Stampfer M; Loda M; Mucci LA
Clin Cancer Res; 2014 Sep; 20(18):4904-11. PubMed ID: 24687926
[TBL] [Abstract][Full Text] [Related]
45. Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer.
Sharad S; Ravindranath L; Haffner MC; Li H; Yan W; Sesterhenn IA; Chen Y; Ali A; Srinivasan A; McLeod DG; Yegnasubramanian S; Srivastava S; Dobi A; Petrovics G
Epigenetics; 2014 Jun; 9(6):918-27. PubMed ID: 24694733
[TBL] [Abstract][Full Text] [Related]
46. Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.
Farrell J; Petrovics G; McLeod DG; Srivastava S
Int J Mol Sci; 2013 Jul; 14(8):15510-31. PubMed ID: 23892597
[TBL] [Abstract][Full Text] [Related]
47. Androgen receptor mutations and polymorphisms in African American prostate cancer.
Koochekpour S; Buckles E; Shourideh M; Hu S; Chandra D; Zabaleta J; Attwood K
Int J Biol Sci; 2014; 10(6):643-51. PubMed ID: 24948877
[TBL] [Abstract][Full Text] [Related]
48. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.
Bose R; Karthaus WR; Armenia J; Abida W; Iaquinta PJ; Zhang Z; Wongvipat J; Wasmuth EV; Shah N; Sullivan PS; Doran MG; Wang P; Patruno A; Zhao Y; ; Zheng D; Schultz N; Sawyers CL
Nature; 2017 Jun; 546(7660):671-675. PubMed ID: 28614298
[TBL] [Abstract][Full Text] [Related]
49. Identification of differentially methylated genes in normal prostate tissues from African American and Caucasian men.
Kwabi-Addo B; Wang S; Chung W; Jelinek J; Patierno SR; Wang BD; Andrawis R; Lee NH; Apprey V; Issa JP; Ittmann M
Clin Cancer Res; 2010 Jul; 16(14):3539-47. PubMed ID: 20606036
[TBL] [Abstract][Full Text] [Related]
50. Race-associated expression of MHC class I polypeptide-related sequence A (MICA) in prostate cancer.
Sakiyama MJ; Espinoza I; Reddy A; de Carlo F; Kumar A; Levenson AS; Bae S; Zhou X; Claudio PP; Lewin J; Manucha V; Pound CR; Vijayakumar S; Gomez CR
Exp Mol Pathol; 2019 Jun; 108():173-182. PubMed ID: 31004600
[TBL] [Abstract][Full Text] [Related]
51. Race-specific coregulatory and transcriptomic profiles associated with DNA methylation and androgen receptor in prostate cancer.
Ramakrishnan S; Cortes-Gomez E; Athans SR; Attwood KM; Rosario SR; Kim SJ; Mager DE; Isenhart EG; Hu Q; Wang J; Woloszynska A
Genome Med; 2024 Apr; 16(1):52. PubMed ID: 38566104
[TBL] [Abstract][Full Text] [Related]
52. Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men.
Kim HS; Moreira DM; Jayachandran J; Gerber L; Bañez LL; Vollmer RT; Lark AL; Donovan MJ; Powell D; Khan FM; Freedland SJ
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):262-5. PubMed ID: 21519348
[TBL] [Abstract][Full Text] [Related]
53. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
[TBL] [Abstract][Full Text] [Related]
54. Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer.
Cullen J; Lynch JA; Klein EA; Van Den Eeden SK; Carroll PR; Mohler JL; Knezevic D; Farrington TA; Lu R
J Urol; 2021 Apr; 205(4):1047-1054. PubMed ID: 33493001
[TBL] [Abstract][Full Text] [Related]
55. High circulating estrogens and selective expression of ERβ in prostate tumors of Americans: implications for racial disparity of prostate cancer.
Abd Elmageed ZY; Moroz K; Srivastav SK; Fang Z; Crawford BE; Moparty K; Thomas R; Abdel-Mageed AB
Carcinogenesis; 2013 Sep; 34(9):2017-23. PubMed ID: 23658372
[TBL] [Abstract][Full Text] [Related]
56. SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence.
Grupp K; Diebel F; Sirma H; Simon R; Breitmeyer K; Steurer S; Hube-Magg C; Prien K; Pham T; Weigand P; Michl U; Heinzer H; Kluth M; Minner S; Tsourlakis MC; Izbicki JR; Sauter G; Schlomm T; Wilczak W
Prostate; 2013 Nov; 73(15):1690-8. PubMed ID: 23843146
[TBL] [Abstract][Full Text] [Related]
57. Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups.
Zaman N; Giannopoulos PN; Chowdhury S; Bonneil E; Thibault P; Wang E; Trifiro M; Paliouras M
PLoS One; 2014; 9(11):e113190. PubMed ID: 25409505
[TBL] [Abstract][Full Text] [Related]
58. Relation of ETS transcription factor family member ERG, androgen receptor and topoisomerase 2β expression to TMPRSS2-ERG fusion status in prostate cancer.
Kolar Z; Burdova A; Jamaspishvili T; Bouchal J; Kucerova R; Bienova M; Kral M; Student V
Neoplasma; 2014; 61(1):9-16. PubMed ID: 24195515
[TBL] [Abstract][Full Text] [Related]
59. Differential expression of Annexin 2, SPINK1, and Hsp60 predict progression of prostate cancer through bifurcated WHO Gleason score categories in African American men.
Beyene DA; Naab TJ; Kanarek NF; Apprey V; Esnakula A; Khan FA; Blackman MR; Brown CA; Hudson TS
Prostate; 2018 Aug; 78(11):801-811. PubMed ID: 29682763
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic analysis identifies factors driving racial disparity in prostate cancer.
Rai R; Yadav SS; Pan H; Khan I; O'Connor J; Alshalalfa M; Davicioni E; Taioli E; Elemento O; Tewari AK; Yadav KK
Cancer Rep (Hoboken); 2019 Apr; 2(2):e1153. PubMed ID: 32721098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
